TC BioPharm (Holdings) PLC (TCBP)
1.46
-0.02
(-1.35%)
USD |
NASDAQ |
May 02, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Price to Book Value: 1.364 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 01, 2024 | 1.382 |
April 30, 2024 | 1.336 |
April 29, 2024 | 1.392 |
April 26, 2024 | 1.429 |
April 25, 2024 | 1.466 |
April 24, 2024 | 1.373 |
April 23, 2024 | 1.476 |
April 22, 2024 | 1.476 |
April 19, 2024 | 1.382 |
April 18, 2024 | 1.326 |
April 17, 2024 | 1.261 |
April 16, 2024 | 1.242 |
April 15, 2024 | 1.224 |
April 12, 2024 | 1.504 |
April 11, 2024 | 1.616 |
April 10, 2024 | 1.588 |
April 09, 2024 | 1.737 |
April 08, 2024 | 1.663 |
April 05, 2024 | 1.775 |
April 04, 2024 | 1.821 |
April 03, 2024 | 1.214 |
April 02, 2024 | 1.186 |
April 01, 2024 | 1.186 |
March 28, 2024 | 0.9293 |
March 27, 2024 | 1.014 |
Date | Value |
---|---|
March 26, 2024 | 1.007 |
March 25, 2024 | 1.022 |
March 22, 2024 | 1.078 |
March 21, 2024 | 1.149 |
March 20, 2024 | 1.092 |
March 19, 2024 | 1.036 |
March 18, 2024 | 1.149 |
March 15, 2024 | 1.192 |
March 14, 2024 | 1.362 |
March 13, 2024 | 1.206 |
March 12, 2024 | 1.277 |
March 11, 2024 | 1.213 |
March 08, 2024 | 0.7519 |
March 07, 2024 | 0.7377 |
March 06, 2024 | 0.7448 |
March 05, 2024 | 0.8938 |
March 04, 2024 | 0.8938 |
March 01, 2024 | 0.9434 |
February 29, 2024 | 0.8938 |
February 28, 2024 | 0.9541 |
February 27, 2024 | 0.9009 |
February 26, 2024 | 0.8583 |
February 23, 2024 | 0.7448 |
February 22, 2024 | 0.8654 |
February 21, 2024 | 0.7731 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2661
Minimum
Feb 05 2024
32.41
Maximum
Feb 17 2023
6.346
Average
3.026
Median
Nov 30 2022
Price to Book Value Benchmarks
Adaptimmune Therapeutics PLC | 7.465 |
Biodexa Pharmaceuticals Plc | 0.9198 |
NuCana PLC | 0.4420 |
Autolus Therapeutics PLC | 9.817 |
Mereo BioPharma Group PLC | 8.646 |
Price to Book Value Related Metrics
PS Ratio | 0.0981 |
Price | 1.46 |
Earnings Yield | -346.3% |
Market Cap | 4.665M |